Daniel Lahana Md Inc is categorized under Internal Medicine Doctors in Beverly Hills, CA and active since 1973.
Daniel Lahana Md Inc was established in 1973, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Lahana at the company’s single location by writing to 465 North Roxbury Drive # 1007, Beverly Hills, California CA 90210 or by phoning (310) 271-5722. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Daniel Lahana Md Inc |
| Contact Person: | Daniel Lahana |
| Address: | 465 North Roxbury Drive # 1007, Beverly Hills, California 90210 |
| Phone Number: | (310) 271-5722 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1973 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Daniel Lahana Md Inc was started in 1973 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Lahana for inquiries that concern Daniel Lahana Md Inc by calling the company number (310) 271-5722, as your correspondence is most welcome. Additionally, the physical location of the single location of Daniel Lahana Md Inc can be found at the coordinates 34.068348,-118.407402 as well as the street address 465 North Roxbury Drive # 1007 in Beverly Hills, California 90210.
For its online presence, you may visit Daniel Lahana Md Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.